Vmn2r111 Inhibitors
Vmn2r111 inhibitors are chemicals that specifically interact with the Vmn2r111 receptor, an entity within the extensive family of vomeronasal type-2 receptors (V2Rs). These receptors are integral to the process of pheromone detection, which is essential for communication within species. Structurally, Vmn2r111 falls under the category of G protein-coupled receptors (GPCRs), which are characterized by their seven transmembrane domains and ability to initiate a cascade of cellular responses upon activation by external stimuli. Vmn2r111 inhibitors bind to this receptor, effectively preventing the normal binding of pheromones and inhibiting the consequent signal transduction pathways that would typically be activated by these chemical signals.
Understanding the role of Vmn2r111 inhibitors involves diving into the molecular dynamics of signal transmission through these receptors. When the normal function of Vmn2r111 is impeded by these inhibitors, researchers can discern the physiological roles attributed to the receptor, shedding light on the intricacies of chemical communication. The inhibitors themselves may come in various forms, including small organic compounds or more complex molecular structures, each designed to bind with high specificity and affinity to the Vmn2r111 receptor. The development of these inhibitors utilizes advanced techniques in molecular modeling and structure-activity relationship (SAR) analysis to fine-tune the interaction between the inhibitor and the receptor. Through the study of these interactions, scientists can gain valuable insights into the receptor's ligand-binding mechanisms and the conformational changes that occur upon activation, thereby contributing to a more comprehensive understanding of chemosensory signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor that can block the EGFR signaling pathway. Although Vmn2r111 is not directly in this pathway, the downstream effects of EGFR inhibition could potentially decrease the expression of genes regulated by EGFR-mediated signaling, which may include Vmn2r111. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that impedes the PI3K/AKT signaling pathway. If Vmn2r111 is indirectly regulated by PI3K/AKT signaling, then its activity could be diminished by this compound. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that acts on the mTOR signaling pathway. This pathway is involved in cell growth and survival, and its inhibition could lead to a reduction in the expression of genes that are downstream of mTOR, potentially including Vmn2r111. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MAPK/ERK inhibitor that could decrease Vmn2r111 expression if the protein is regulated by the MAPK/ERK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that suppresses inflammation and stress response pathways. If Vmn2r111 is modulated by these pathways, its activity could be indirectly inhibited by SB203580. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that interferes with the RhoA/ROCK signaling pathway. Inhibition of this pathway could lead to altered cell adhesion and motility, potentially affecting the expression or function of Vmn2r111 if it is related to these processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor that can disrupt the MEK/ERK signaling pathway, potentially leading to decreased expression or function of Vmn2r111 if it is regulated by this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that may impede cell stress responses. If Vmn2r111 is implicated in such responses, its function could be indirectly diminished by SP600125. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor similar to LY294002. It could lead to a decrease in Vmn2r111 activity by affecting the PI3K/AKT pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src kinase inhibitor that may indirectly impact Vmn2r111 if its expression or function is modulated by Src kinase signaling pathways. | ||||||